The Journal of Maternal-Fetal & Neonatal Medicine
Volume 36, 2023 - Issue 1
Original Article
Comparison of adverse reactions of spiramycin versus pyrimethamine/sulfadiazine treatment of toxoplasmosis in pregnancy: is spiramycin really the drug of choice for unproven infection of the fetus?
Petr Prasila Department of Infectious Diseases, Charles University, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic
https://orcid.org/0000-0003-1943-9366View further author information
https://orcid.org/0000-0003-1943-9366View further author information, Radek Slehab Department of Epidemiology, University of Defence, Faculty of Military Health Sciences, Hradec Kralove, Czech Republichttps://orcid.org/0000-0001-7359-9147View further author information
https://orcid.org/0000-0001-7359-9147View further author information, Marian Kacerovskyc Department of Obstetrics and Gynecology, Charles University, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republichttps://orcid.org/0000-0001-9858-7900View further author information
https://orcid.org/0000-0001-9858-7900View further author information & Pavel Bostikd Institute of Clinical Microbiology, Charles University, Faculty of Medicine and University Hospital, Hradec Kralove, Czech RepublicCorrespondence[email protected]
https://orcid.org/0000-0003-2691-6458View further author information
https://orcid.org/0000-0003-2691-6458View further author information